Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Time to see the light.
Subcortical atrophy and cognition: Sex effects in multiple sclerosis.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Molecular Mechanisms Underlying the Effects of Statins in the Central Nervous System.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Detection of inflammatory biomarkers in saliva and urine: Potential in diagnosis, prevention, and treatment for chronic diseases.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Variables associated with patient activation in persons with multiple sclerosis.
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Towards establishing MS prevalence in Latin America and the Caribbean.
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases.
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
MiR-30a inhibits Th17 differentiation and demyelination of EAE mice by targeting the IL-21R.
Distraction adds to the cognitive burden in multiple sclerosis.
New TYSABRI® data show earlier treatment and longer-term use result in significant reductions in MS disease activity
Effect of Multiple Infusions of AIN457 on Disease Activity in Relapsing-remitting Multiple Sclerosis
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
Multiplexing analysis of the polyspecific intrathecal immune response in multiple sclerosis.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
Cost-effectiveness of early initiation of fingolimod versus delayed initiation after 1 year of intramuscular interferon Beta-1a in patients with multiple sclerosis.
Contribution of imaging to the diagnosis of optic neuropathies.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.

Pages